Breaking News

Lonza Introduces X-Ray Powder Diffraction Capability at Monteggio Site

Strengthens its micronization portfolio and expands its range of particle engineering services.

Author Image

By: Charlie Sternberg

Associate Editor

Lonza has expanded the range of particle engineering services offered by its Monteggio (CH) site through the introduction of X-ray powder diffraction (XRPD). This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs).   Micronization via jet milling is a well-established technique to control the particle size of APIs and enhance their processing, bioavailability, and dissolution rates. However, as m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters